原发性中枢神经系统间变性大细胞淋巴瘤是一种罕见的脑肿瘤

Q4 Medicine

European Oncology and Haematology Pub Date : 2014-01-01 DOI:10.17925/EOH.2014.10.1.48

D. Papadatos-Pastos, J. Hall, R. Pettengell, L. Bridges, B. Newell, J. Samol

{"title":"原发性中枢神经系统间变性大细胞淋巴瘤是一种罕见的脑肿瘤","authors":"D. Papadatos-Pastos, J. Hall, R. Pettengell, L. Bridges, B. Newell, J. Samol","doi":"10.17925/EOH.2014.10.1.48","DOIUrl":null,"url":null,"abstract":"© TOUCH MEDICAL MEDIA 2014 Abstract We present a case of a 64-year-old man who was diagnosed with a primary anaplastic large cell lymphoma of the central nervous system (PCNSAL). He had received radical chemotherapy and radiotherapy for a non-small cell lung cancer (NSCLC) in the past. There is no known association between NSCLC and PCNSAL. We describe the diagnostic and therapeutic challenges associated with these rare intracranial lymphomas and highlight the potential role of newer biological agents in patients with anaplastic lymphoma kinase (ALK-1) positive PCNSAL.","PeriodicalId":38554,"journal":{"name":"European Oncology and Haematology","volume":"440 1","pages":"48"},"PeriodicalIF":0.0000,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Primary Central Nervous System Anaplastic Large Cell Lymphoma is an Unusual Brain Tumour\",\"authors\":\"D. Papadatos-Pastos, J. Hall, R. Pettengell, L. Bridges, B. Newell, J. Samol\",\"doi\":\"10.17925/EOH.2014.10.1.48\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"© TOUCH MEDICAL MEDIA 2014 Abstract We present a case of a 64-year-old man who was diagnosed with a primary anaplastic large cell lymphoma of the central nervous system (PCNSAL). He had received radical chemotherapy and radiotherapy for a non-small cell lung cancer (NSCLC) in the past. There is no known association between NSCLC and PCNSAL. We describe the diagnostic and therapeutic challenges associated with these rare intracranial lymphomas and highlight the potential role of newer biological agents in patients with anaplastic lymphoma kinase (ALK-1) positive PCNSAL.\",\"PeriodicalId\":38554,\"journal\":{\"name\":\"European Oncology and Haematology\",\"volume\":\"440 1\",\"pages\":\"48\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2014-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Oncology and Haematology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.17925/EOH.2014.10.1.48\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Oncology and Haematology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17925/EOH.2014.10.1.48","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

摘要

©TOUCH MEDICAL MEDIA 2014摘要我们报告一例64岁男性被诊断为原发性中枢神经系统间变性大细胞淋巴瘤(PCNSAL)。他曾因非小细胞肺癌(NSCLC)接受过根治性化疗和放疗。NSCLC和PCNSAL之间没有已知的关联。我们描述了与这些罕见颅内淋巴瘤相关的诊断和治疗挑战，并强调了新型生物制剂在间变性淋巴瘤激酶(ALK-1)阳性PCNSAL患者中的潜在作用。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Primary Central Nervous System Anaplastic Large Cell Lymphoma is an Unusual Brain Tumour

© TOUCH MEDICAL MEDIA 2014 Abstract We present a case of a 64-year-old man who was diagnosed with a primary anaplastic large cell lymphoma of the central nervous system (PCNSAL). He had received radical chemotherapy and radiotherapy for a non-small cell lung cancer (NSCLC) in the past. There is no known association between NSCLC and PCNSAL. We describe the diagnostic and therapeutic challenges associated with these rare intracranial lymphomas and highlight the potential role of newer biological agents in patients with anaplastic lymphoma kinase (ALK-1) positive PCNSAL.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

European Oncology and Haematology Medicine-Hematology

自引率

0.00%

发文量